Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial von Uccelli, Antonio, Laroni, Alice, Ali, Rehiana, Battaglia, Mario Alberto, Blinkenberg, Morten, Brundin, Lou, Clanet, Michel, Fernandez, Oscar, Marriott, James, Muraro, Paolo, Nabavi, Seyed Massood, Oliveri, Roberto S, Radue, Ernst, Ramo Tello, Cristina, Schiavetti, Irene, Sellner, Johann, Sorensen, Per Soelberg, Sormani, Maria Pia, Wuerfel, Jens Thomas, Freedman, Mark S, Aghdami, Naser, Agüera-Morales, Eduardo, Ali, Rehiana, Allan, David, Arab, Leila, Battaglia, Mario, Berry, Isabelle, Blinkenberg, Morten, Bonetti, Bruno, Brundin, Lou, Capelli, Chiara, Castellan, Lucio, Cellerino, Maria, Cencioni, Maria Teresa, Clanet, Michel, Comi, Giancarlo, Courtman, David, Dazzi, Francesco, Fischer-Nielsen, Anne, Fernandez, Oscar, Fernandez, Victoria, Freedman, Mark S., Furlan, Roberto, Gimona, Mario, Gualandi, Francesca, Guan, Qingdong, Iacobaeus, Ellen, Inglese, Matilde, Introna, Martino, Izquierdo, Guillermo, Karimi, Shahedeh, Laroni, Alice, Le Blanc, Katarina, Loaiza, Sandra, Mallik, Shahrukh, Marley, Stephen, Marrie, Ruth Ann, Marriot, James, Martino, Gianvito, Nabavi, Seyed Massood, Miller, David, Muraro, Paolo A., Nicholas, Richard, Oliveri, Roberto S, Orengo, Giovanni, Palanicawande, Renuka, Pardini, Matteo, Radue, Ernst W, Ramo Tello, Cristina, Rush, Carolina, Schiavetti, Irene, Sellner, Johann, Sensebe, Luc, Soelberg Sorensen, Per, Sormani, Maria Pia, Strunk, Dirk, Szwajcer, David, Thalamas, Claire, Uccelli, Antonio, Wuerfel, Jens Thomas

Volltext

Predicting therapeutic response to fingolimod treatment in multiple sclerosis patients von Quirant‐Sánchez, Bibiana, Hervás‐García, José V., Teniente‐Serra, Aina, Brieva, Luis, Moral‐Torres, Ester, Cano, Antonio, Munteis, Elvira, Mansilla, María J., Presas‐Rodriguez, Silvia, Navarro‐Barriuso, Juan, Ramo‐Tello, Cristina, Martínez‐Cáceres, Eva M.

Volltext

Optimal response to dimethyl fumarate is mediated by a reduction of Th1‐like Th17 cells after 3 months of treatment von Mansilla, María José, Navarro‐Barriuso, Juan, Presas‐Rodríguez, Silvia, Teniente‐Serra, Aina, Quirant‐Sánchez, Bibiana, Ramo‐Tello, Cristina, Martínez‐Cáceres, Eva María

Volltext

Monitoring CD49d Receptor Occupancy: A Method to Optimize and Personalize Natalizumab Therapy in Multiple Sclerosis Patients von Puñet‐Ortiz, Joan, Hervás‐García, José Vicente, Teniente‐Serra, Aina, Cano‐Orgaz, Antonio, Mansilla, Maria José, Quirant‐Sánchez, Bibiana, Navarro‐Barriuso, Juan, Fernández‐Sanmartín, Marco A., Presas‐Rodríguez, Silvia, Ramo‐Tello, Cristina, Martínez‐Cáceres, Eva María

Volltext

Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study von Sancho-Saldaña, Agustín, Gil-Sánchez, Anna, González-Mingot, Cristina, Peralta, Silvia, Solana, Maria Jose, Torres, Pascual, Juanes, Alba, Quibus, Laura, Ruiz, Emilio, Sanpedro, Eduardo, Quirant-Sánchez, Bibiana, Martínez-Cáceres, Eva, Ramo Tello, Cristina, Presas-Rodríguez, Silvia, García Rubio, Sebatián, Baron, Beatriz Pardiñas, Ramió-Torrentà, Lluís, Sotoca, Javier, González-Suárez, Inés, Eichau, Sara, Prieto-González, José M, Blasco Quilez, Maria Rosario, Sabín-Muñoz, Julia, Sánchez-López, Antonio José, Llorens Calatayud, Gloria, Calles, Carmen, Sempere, Ángel Pérez, Garcés, Moises, Carmona, Olga, Moral, Ester, Hervás, José Vicente, Blanco, Yolanda, Sola-Valls, Nuria, Tellez Lara, Nieves, Forero, Lucía, Brieva, Luis

Volltext

Case report: tumefactive demyelinating lesions after the second cycle of alemtuzumab in multiple sclerosis; immune cell profile and biomarkers von Rabaneda-Lombarte, Neus, Teniente-Serra, Aina, Massuet-Vilamajó, Anna, Ramo-Tello, Cristina, Presas-Rodríguez, Silvia

Volltext

Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSD von Siriratnam, Pakeeran, Huda, Saif, Van Der Walt, Anneke, Sanfilippo, Paul G, Sharmin, Sifat, Foong, Yi Chao, Yeh, Wei Z, Zhu, Chao, Khoury, Samia J, Csepany, Tunde, Willekens, Barbara, Etemadifar, Masoud, Ozakbas, Serkan, Nytrova, Petra, Altintas, Ayse, Al-Asmi, Abdullah, Ramo-Tello, Cristina M, Laureys, Guy, Patti, Francesco, Horakova, Dana, Foschi, Matteo, Boz, Cavit, Mccombe, Pamela A, Turkoglu, Recai, Lechner-Scott, Jeannette, Roos, Izanne, Kalincik, Tomas, Jokubaitis, Vilija G, Butzkueven, Helmut, Monif, Mastura

Volltext

Epstein-Barr Virus and Multiple Sclerosis: A Convoluted Interaction and the Opportunity to Unravel Predictive Biomarkers von Ortega-Hernandez, Oscar-Danilo, Martínez-Cáceres, Eva M, Presas-Rodríguez, Silvia, Ramo-Tello, Cristina

Volltext

Stable antigen‐specific T‐cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients von Raϊch‐Regué, Dàlia, Grau‐López, Laia, Naranjo‐Gómez, Mar, Ramo‐Tello, Cristina, Pujol‐Borrell, Ricardo, Martínez‐Cáceres, Eva, Borràs, Francesc E.

Volltext

Vitamin D3-Induced Tolerogenic Dendritic Cells Modulate the Transcriptomic Profile of T CD4 + Cells Towards a Functional Hyporesponsiveness von Navarro-Barriuso, Juan, Mansilla, María José, Quirant-Sánchez, Bibiana, Teniente-Serra, Aina, Ramo-Tello, Cristina, Martínez-Cáceres, Eva M

Volltext

Single‐cell multi‐omics analysis of COVID‐19 patients with pre‐existing autoimmune diseases shows aberrant immune responses to infection von Barmada, Anis, Handfield, Louis‐François, Godoy‐Tena, Gerard, Calle‐Fabregat, Carlos, Ciudad, Laura, Arutyunyan, Anna, Andrés‐León, Eduardo, Hoo, Regina, Porter, Tarryn, Oszlanczi, Agnes, Richardson, Laura, Calero‐Nieto, Fernando J., Wilson, Nicola K., Marchese, Domenica, Sancho‐Serra, Carmen, Carrillo, Jorge, Presas‐Rodríguez, Silvia, Ramo‐Tello, Cristina, Ruiz‐Sanmartin, Adolfo, Ferrer, Ricard, Ruiz‐Rodriguez, Juan Carlos, Martínez‐Gallo, Mónica, Munera‐Campos, Mónica, Carrascosa, Jose Manuel, Göttgens, Berthold, Heyn, Holger, Prigmore, Elena, Casafont‐Solé, Ivette, Solanich, Xavier, Sánchez‐Cerrillo, Ildefonso, González‐Álvaro, Isidoro, Raimondo, Maria Gabriella, Ramming, Andreas, Martin, Javier, Martínez‐Cáceres, Eva, Ballestar, Esteban, Vento‐Tormo1, Roser, Rodríguez‐Ubreva, Javier

Volltext

Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis von Roos, Izanne, Sharmin, Sifat, Malpas, Charles, Ozakbas, Serkan, Lechner-Scott, Jeannette, Hodgkinson, Suzanne, Alroughani, Raed, Eichau Madueño, Sara, Boz, Cavit, van der Walt, Anneke, Butzkueven, Helmut, Buzzard, Katherine, Skibina, Olga, Foschi, Matteo, Grand’Maison, Francois, John, Nevin, Grammond, Pierre, Terzi, Murat, Prévost, Julie, Barnett, Michael, Laureys, Guy, Van Hijfte, Liesbeth, Luis Sanchez-Menoyo, Jose, Blanco, Yolanda, Oh, Jiwon, McCombe, Pamela, Ramo Tello, Cristina, Soysal, Aysun, Prat, Alexandre, Duquette, Pierre, Yamout, Bassem I, Khoury, Samia, van Pesch, Vincent, Macdonell, Richard, José Sá, Maria, Slee, Mark, Kuhle, Jens, Maimone, Davide, Spitaleri, Daniele LA, Willekens, Barbara, Asmi, Abdallah Al, Tallantyre, Emma, Robertson, Neil P, Coles, Alasdair, L Brown, J William, Kalincik, Tomas

Volltext

MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of m... von Uccelli, Antonio, Laroni, Alice, Brundin, Lou, Clanet, Michel, Fernandez, Oscar, Nabavi, Seyed Massood, Muraro, Paolo A, Oliveri, Roberto S, Radue, Ernst W, Sellner, Johann, Soelberg Sorensen, Per, Sormani, Maria Pia, Wuerfel, Jens Thomas, Battaglia, Mario A, Freedman, Mark S

Volltext

Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis von Diouf, Ibrahima, Malpas, Charles B., Sharmin, Sifat, Roos, Izanne, Horakova, Dana, Havrdova, Eva Kubala, Patti, Francesco, Shaygannejad, Vahid, Ozakbas, Serkan, Izquierdo, Guillermo, Eichau, Sara, Onofrj, Marco, Lugaresi, Alessandra, Alroughani, Raed, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Terzi, Murat, Boz, Cavit, Grand'Maison, Francois, Hamdy, Sherif, Sola, Patrizia, Ferraro, Diana, Grammond, Pierre, Turkoglu, Recai, Buzzard, Katherine, Skibina, Olga, Yamout, Bassem, Altintas, Ayse, Gerlach, Oliver, Pesch, Vincent, Blanco, Yolanda, Maimone, Davide, Lechner‐Scott, Jeannette, Bergamaschi, Roberto, Karabudak, Rana, Iuliano, Gerardo, McGuigan, Chris, Cartechini, Elisabetta, Barnett, Michael, Hughes, Stella, Sa, Maria José, Solaro, Claudio, Kappos, Ludwig, Ramo‐Tello, Cristina, Cristiano, Edgardo, Hodgkinson, Suzanne, Spitaleri, Daniele, Soysal, Aysun, Petersen, Thor, Slee, Mark, Butler, Ernest, Granella, Franco, Gans, Koen, McCombe, Pamela, Ampapa, Radek, Van Wijmeersch, Bart, Walt, Anneke, Butzkueven, Helmut, Prevost, Julie, Sinnige, L. G. F., Sanchez‐Menoyo, Jose Luis, Vucic, Steve, Laureys, Guy, Van Hijfte, Liesbeth, Khurana, Dheeraj, Macdonell, Richard, Gouider, Riadh, Castillo‐Triviño, Tamara, Gray, Orla, Aguera‐Morales, Eduardo, Al‐Asmi, Abdullah, Shaw, Cameron, Deri, Norma, Al‐Harbi, Talal, Fragoso, Yara, Csepany, Tunde, Perez Sempere, Angel, Trevino‐Frenk, Irene, Schepel, Jan, Moore, Fraser, Kalincik, Tomas

Volltext

Beneficial Effect of Tolerogenic Dendritic Cells Pulsed with MOG Autoantigen in Experimental Autoimmune Encephalomyelitis von Mansilla, María José, Sellès‐Moreno, Carla, Fàbregas‐Puig, Sara, Amoedo, Joan, Navarro‐Barriuso, Juan, Teniente‐Serra, Aina, Grau‐López, Laia, Ramo‐Tello, Cristina, Martínez‐Cáceres, Eva M.

Volltext

Combined Therapy of Vitamin D3-Tolerogenic Dendritic Cells and Interferon-β in a Preclinical Model of Multiple Sclerosis von Quirant-Sánchez, Bibiana, Mansilla, María José, Navarro-Barriuso, Juan, Presas-Rodríguez, Silvia, Teniente-Serra, Aina, Fondelli, Federico, Ramo-Tello, Cristina, Martínez-Cáceres, Eva

Volltext

MAP7 and MUCL1 Are Biomarkers of Vitamin D3-Induced Tolerogenic Dendritic Cells in Multiple Sclerosis Patients von Navarro-Barriuso, Juan, Mansilla, María José, Quirant-Sánchez, Bibiana, Ardiaca-Martínez, Alicia, Teniente-Serra, Aina, Presas-Rodríguez, Silvia, Ten Brinke, Anja, Ramo-Tello, Cristina, Martínez-Cáceres, Eva M

Volltext

Th1Th17CM Lymphocyte Subpopulation as a Predictive Biomarker of Disease Activity in Multiple Sclerosis Patients under Dimethyl Fumarate or Fingolimod Treatment von Navarro-Barriuso, Juan, Martínez-Cáceres, Eva, Ramo-Tello, Cristina, Cano, Antonio, Moral-Torres, Ester, Brieva, Luis, Hervás-García, José V., Teniente-Serra, Aina, Mansilla, María José, Presas-Rodriguez, Silvia, Quirant-Sánchez, Bibiana, Munteis, Elvira

Volltext

Baseline Differences in Minor Lymphocyte Subpopulations may Predict Response to Fingolimod in Relapsing–Remitting Multiple Sclerosis Patients von Teniente‐Serra, Aina, Hervás, José Vicente, Quirant‐Sánchez, Bibiana, Mansilla, María José, Grau‐López, Laia, Ramo‐Tello, Cristina, Martínez‐Cáceres, Eva María

Volltext

Transverse Myelitis Affecting More Than 4 Spinal Segments Associated with Systemic Lupus Erythematosus: Clinical, Immunological, and Radiological Characteristics of 22 Patients von Espinosa, Gerard, MD, PhD, Mendizábal, Andrea, MD, Mínguez, Sonia, MD, Ramo-Tello, Cristina, MD, Capellades, Jaume, MD, IDI, Olivé, Alejandro, MD, PhD, Cervera, Ricard, MD, PhD

Volltext